I guess the best one can do is assume that it follows the pattern of the recent past.
So I take that to mean revenue in H2 FY17 to be 10% to 20% less than that of H1 FY17. Now if costs have gone up relative to pcp's, then clearly NPAT will be something else again.
- Forums
- ASX - By Stock
- ASW
- Ann: Preliminary Profit Advice
Ann: Preliminary Profit Advice, page-3
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASW (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online